BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27975336)

  • 1. Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.
    Kappelle WF; Valk GD; Leenders M; Moons LM; Bogte A; Siersema PD; Vleggaar FP
    Endoscopy; 2017 Jan; 49(1):27-34. PubMed ID: 27975336
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome.
    Dʼsouza SL; Elmunzer BJ; Scheiman JM
    J Clin Gastroenterol; 2014; 48(5):458-61. PubMed ID: 24356459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study.
    Tamagno G; Scherer V; Caimo A; Bergmann SR; Kann PH
    Digestion; 2018; 98(2):112-118. PubMed ID: 29698969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
    Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
    World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
    Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
    Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
    Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters.
    Faggiano A; Modica R; Lo Calzo F; Camera L; Napolitano V; Altieri B; de Cicco F; Bottiglieri F; Sesti F; Badalamenti G; Isidori AM; Colao A
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31586182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
    Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
    Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
    Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumours.
    Alsohaibani F; Bigam D; Kneteman N; Shapiro AM; Sandha GS
    Can J Gastroenterol; 2008 Oct; 22(10):817-20. PubMed ID: 18925304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort.
    van Beek DJ; Verkooijen HM; Nell S; Bonsing BA; van Eijck CH; van Goor H; Hoogwater FJH; Nieveen van Dijkum EJM; Kazemier G; Dejong CHC; Brosens LAA; Wessels FJ; Borel Rinkes IHM; Valk GD; Vriens MR
    Neuroendocrinology; 2021; 111(8):705-717. PubMed ID: 32721974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors.
    Kongkam P; Al-Haddad M; Attasaranya S; O'Neil J; Pais S; Sherman S; DeWitt J
    Endoscopy; 2008 Jul; 40(7):602-5. PubMed ID: 18612947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental benefit of preoperative EUS for the detection of pancreatic neuroendocrine tumors: a meta-analysis.
    James PD; Tsolakis AV; Zhang M; Belletrutti PJ; Mohamed R; Roberts DJ; Heitman SJ
    Gastrointest Endosc; 2015 Apr; 81(4):848-56.e1. PubMed ID: 25805462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rupture of small cystic pancreatic neuroendocrine tumor with many microtumors.
    Sagami R; Nishikiori H; Ikuyama S; Murakami K
    World J Gastroenterol; 2017 Oct; 23(37):6911-6919. PubMed ID: 29085235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.
    Khashab MA; Yong E; Lennon AM; Shin EJ; Amateau S; Hruban RH; Olino K; Giday S; Fishman EK; Wolfgang CL; Edil BH; Makary M; Canto MI
    Gastrointest Endosc; 2011 Apr; 73(4):691-6. PubMed ID: 21067742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
    Daskalakis K; Tsoli M; Alexandraki KI; Angelousi A; Chatzellis E; Tsolakis AV; Karoumpalis I; Kolomodi D; Kassi E; Kaltsas G
    Horm Metab Res; 2019 Sep; 51(9):580-585. PubMed ID: 31295747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.